<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Jameshebrew - Latest News</title>
<link href="https://news.arcnewswire.com/rss/jameshebrew/latest.xml"></link>
<updated>2026-09-20T00:44:03+00:00</updated>
<id>urn:uuid:05a9f158-0bd1-2190-0654-c78a08334acc</id>
<entry>
<title>Patient Recruitment and Retention Services Marker, 2019-2030 by Roots Analysis</title>
<link href="https://news.arcnewswire.com/@jameshebrew/patient-recruitment-and-retention-services-marker-2019-2030-by-roots-analysis-k436rne5m3ra"></link>
<id>urn:uuid:d3ab17d6-ab43-1214-2f40-6a4bbabc3b8d</id>
<summary type="html"><![CDATA[A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers]]></summary>
<updated>2021-09-02T08:05:38+00:00</updated>
</entry>
<entry>
<title>Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market By Rootsanalysis</title>
<link href="https://news.arcnewswire.com/@jameshebrew/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-by-rootsanalysis-b68qerrjk8dj"></link>
<id>urn:uuid:baf542e4-0961-e3d3-6994-842bbc577958</id>
<summary type="html"><![CDATA[Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access]]></summary>
<updated>2021-08-31T06:33:58+00:00</updated>
</entry>
<entry>
<title>Drug Repurposing Service Providers Market, 2020-2030 By Roots Analysis</title>
<link href="https://news.arcnewswire.com/@jameshebrew/drug-repurposing-service-providers-market-2020-2030-by-roots-analysis-4n3bawwwy8pq"></link>
<id>urn:uuid:a828a7d4-817d-51da-99fc-c288580007c5</id>
<summary type="html"><![CDATA[Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs]]></summary>
<updated>2021-08-31T05:19:11+00:00</updated>
</entry>
</feed>